AUTHORS
Arun Augustine, MD, Roger Spear, PharmD2, Hilary Bertucci, RN, OCN3, Moniba Nazeef, MD4
AFFILIATIONS
1 University of Wisconsin-Madison, Madison, Wisconsin, United States, William S. Middleton Memorial Veterans' Hospital, Madison, Wisconsin, United States, William S. Middleton Memorial Veterans' Hospital, Madison, Wisconsin, United States
2 William S. Middleton Memorial Veterans' Hospital, Madison, Wisconsin, United States
3 William S. Middleton Memorial Veterans' Hospital, Madison, Wisconsin, United States
4 William S. Middleton Memorial Veterans' Hospital, Madison, Wisconsin, United States
ABSTRACT
Little evidence is available to guide the administration of blood products, especially in the outpatient setting. It was noticed at our VA Infusion Clinic that transfusion rates for packed red blood cells (pRBC's) were highly variable, regardless of individual patient risk factors for transfusion-associated circulatory overload (TACO) such as a history of heart failure, CKD, or daily diuretic use. Via a multi-disciplinary committee, we implemented educational tools directed at nursing staff and healthcare providers that shared the available data on safe pRBC transfusion practices as well as recommendations to administer pRBC's at faster recommended rates while also identifying patients at risk for TACO. This project was first initiated on 12/8/25 and had a SMART aim of reducing the average transfusion time of pRBC’s in our clinic by 10% by 5/1/26.
Our multi-disciplinary team included a lead hematologist, an infusion clinic pharmacist, an infusion clinic nurse, and a Chief Resident for Quality and Safety. To collect baseline data, patients who had received pRBC's between 1/1/25-2/28/26 were identified via a systematic query of blood product transfusion orders. Patient encounters were reviewed manually to record relevant past medical history as well as the number of units of pRBC's, transfusion rates, and total transfusion times sourced from nursing documentation notes. All transfusions began at 75 mL/hr for 15 minutes, per institutional guidelines. This time was included in the measured total transfusion times. Following review of baseline data, process mapping and a general needs assessment were conducted to guide our intervention design. Post-intervention data collection was identical. Transfusion rates between groups were analyzed using Mann-Whitney non-parametric testing with a two-tailed significance threshold of p>0.05.
Our baseline data showed that 173 units of pRBC's were transfused to 36 unique patients in the Madison VA Infusion Clinic from 1/1/25-2/28/26. The mean transfusion rate was 210.2 mL/hr (95% CI 207.2-213.3) and the mean transfusion time was 104.9 minutes (95% CI 102.7-107.1). These patients often had multiple risk factors for TACO with only 33% (12/36) having no history of heart failure, CKD, or daily diuretic use. No complications were documented during this time. After our process mapping and general needs assessment, staff uncertainty on optimal transfusion rates and TACO risk factors seemed to be the most common barriers to rapid transfusion rates. As such, we selected an education-based intervention to address these knowledge gaps by reviewing our institutional data and best practice recommendations at least weekly to infusion clinic nursing staff during morning pre-clinic rounds. Following the implementation of our intervention on 3/1/2026, 22 units of pRBC's were transfused into 10 unique patients over a 90-day period. The post-intervention mean transfusion rate increased by 37% to 286.8 mL/hr (95% CI 263.3-301.1; p<0.0001). This corresponded with a post-intervention mean transfusion time reduction of 19% to 85.0 minutes (95% CI 79.7-94.6; p<0.0001). Additionally, no transfusion reactions of any type were observed during the post-intervention transfusions.
Via a multi-disciplinary approach, regular nursing and provider education increased the mean transfusion rate of pRBC's by 36.6%, leading to a 19% reduction in the mean total transfusion time without any observed transfusion reactions. By providing more efficient patient care, we hope to reduce the detrimental effects of time toxicity and unnecessary healthcare costs. Future work is needed to monitor this new protocol for adverse effects and determine the optimal transfusion rate for our veterans while also trying to optimize other potential delays in outpatient transfusions including nurse scheduling, blood product acquisition, and post-transfusion monitoring practices.
DISCLOSURES
Arun Augustine, MD: No relevant conflicts of interest to declare.